Literature DB >> 8126057

Calcitonin receptors on neoplastic mononuclear cells cultured from a human giant-cell tumor of the sacrum.

A Maeda1, H Matsui, M Kanamori, K Yudoh, H Tsuji.   

Abstract

Saturable, specific, high-affinity calcitonin receptors were demonstrated in cultured neoplastic mononuclear spindle cells from a giant-cell tumor of the sacrum of a 38-year-old woman. The receptor was analyzed by autoradiography and 125I-calcitonin binding assay. Binding reversibility of 125I-calcitonin to the cells was not complete and the structural specificity was indicated by the inability of unrelated hormones to compete with calcitonin. The 24,000 receptors/cell and dissociation constant (Kd) of 8.0 x 10(-10) M, calculated from linear Scatchard plots, suggested the existence of a single class of calcitonin binding sites in the neoplastic mononuclear cells. Flow-cytometric analysis in the primary culture showed that mononuclear cells consisted of mononuclear round cells of monocyte/macrophage lineage, which express more calcitonin receptors than neoplastic mononuclear spindle cells. Administration of calcitonin caused morphological and physiological alterations, resulting in involutional or irregular cytoplasmic shapes and inhibition of DNA synthesis in neoplastic mononuclear cells accompanied by the escape phenomenon. Cells preincubated with calcitonin showed a decrease in 125I-calcitonin binding activity, which could account for the escape phenomenon. The decrease in 125I-calcitonin binding was rapid, but the recovery was not observed for 24 h after elimination of calcitonin. This decrease may be caused by the disappearance of residual receptors or by a decrease in calcitonin affinity. The calcitonin-induced morphological changes and the inhibition of DNA synthesis of cells were revealed to be mediated by calcitonin receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8126057     DOI: 10.1007/bf01236383

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Calcitonin therapy of aneurysmal bone cysts.

Authors:  M Szendröi; I Antal; G Liszka; A Kónya
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Calcitonin receptors of human osteoclastoma.

Authors:  G C Nicholson; M A Horton; P M Sexton; C S D'Santos; J M Moseley; B E Kemp; J A Pringle; T J Martin
Journal:  Horm Metab Res       Date:  1987-11       Impact factor: 2.936

3.  Induction of antibodies to porcine ACTH in rabbits with nonsteroidogenic polymers of BSA and ACTH.

Authors:  M Reichlin; J J Schnure; V K Vance
Journal:  Proc Soc Exp Biol Med       Date:  1968-06

4.  Human giant cell tumors of bone identification and characterization of cell types.

Authors:  S R Goldring; M S Roelke; K K Petrison; A K Bhan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

5.  Characterization of cells cultured from human giant-cell tumors of bone. Phenotypic relationship to the monocyte-macrophage and osteoclast.

Authors:  S Komiya; Y Sasaguri; A Inoue; M Nakashima; S Yamamoto; I Yanagida; M Morimatsu
Journal:  Clin Orthop Relat Res       Date:  1990-09       Impact factor: 4.176

6.  Protein kinase-C-induced down-regulation of calcitonin receptors and calcitonin-activated adenylate cyclase in T47D and BEN cells.

Authors:  D M Findlay; V P Michelangeli; P J Robinson
Journal:  Endocrinology       Date:  1989-11       Impact factor: 4.736

7.  Delineation of four cell types comprising the giant cell tumor of bone. Expression of Ia and monocyte-macrophage lineage antigens.

Authors:  G R Burmester; R J Winchester; A Dimitriu-Bona; M Klein; G Steiner; H A Sissons
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

8.  Calcitonin and 1,25-dihydroxyvitamin D3 receptors in human breast cancer cell lines.

Authors:  D M Findlay; V P Michelangeli; J A Eisman; R J Frampton; J M Moseley; I MacIntyre; R Whitehead; T J Martin
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

9.  Transforming growth factor-beta modulates receptor binding of calciotropic hormones and G protein-mediated adenylate cyclase responses in osteoblast-like cells.

Authors:  H G Schneider; V P Michelangeli; R J Frampton; J L Grogan; K Ikeda; T J Martin; D M Findlay
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

10.  Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexes.

Authors:  H G Schneider; F Raue; A Zink; A Koppold; R Ziegler
Journal:  Mol Cell Endocrinol       Date:  1988-07       Impact factor: 4.102

View more
  1 in total

1.  Non-surgical treatment as an alternative for the management of central giant cell granuloma: a systematic review.

Authors:  Camila Camarini; Elen de Souza Tolentino
Journal:  Clin Oral Investig       Date:  2021-10-01       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.